Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on R 1 Aminoindane. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105063161B reveals high-purity R-1-aminoindane production. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN105063162A reveals dynamic kinetic resolution for high-purity chiral intermediates. Achieve substantial cost reduction and supply chain reliability in pharmaceutical manufacturing processes.
This novel chiral resolution method offers high purity and significant cost efficiency for global pharmaceutical intermediate manufacturing supply chains today.
Patent CN105017035B details a high-purity DKR method for chiral intermediates. Achieves >99% ee with scalable catalysts for reliable pharmaceutical supply chains.